Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ubichem Research, founded in 1996, is a CRO/CMO specializing in chemistry services for pharmaceutical development. It provides custom synthesis, process R&D, analytical methods, and radiolabelling, manufacturing intermediates and APIs up to cGMP standards, focusing on early-stage small molecule drug development. It was acquired by Ubichem and operates as part of the larger Ubichem Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ubichem Research.